Collaboration with Industry and Start Up Community
IALS seeks to become the catalyst for applied life science programs on campus and enable industry/academic alliances. To achieve this IALS is creating a ‘portfolio’ of translational life science projects based on faculty and student strengths in basic sciences on this campus and from collaborators. This project portfolio is regularly evaluated by a group of expert industry advisors that form Industry Advisory Boards (IABs) for each of the three Centers and for IALS overall, and also by a group of Business Innovation Fellows that provide business guidance to prioritized portfolio projects. Prioritized projects are also eligible for resourcing, and are advanced towards the development of product candidates.
IALS is also developing new business models for establishing win/win industry/academia collaborations based on the concept of risk-sharing. These models are being developed with a group of ‘Entrepreneurs-in-Residence’, and by the Business Innovation Fellows in collaboration with the Isenberg School of Management and its Berthiaume Center for Entrepreneurship. Furthermore, IALS also provides an interface between industry and faculty/students.
Overall, these capabilities position UMass Amherst as a regional resource for applied life sciences, novel industry relationships, and economic development in Massachusetts.
What are IALS ‘Collaboratories’?
Collaboratories are research laboratory spaces for industry partners. IALS has space for up to 16 industry partners which can include start-up companies emerg-ing from faculty research projects, to partnerships with more established companies that seek space on campus to develop medical devices, healthcare/life science related product candidates. Collaboratory occupants will have access to 30 IALS Core Facilities. Spaces are adaptable to individual needs, and flexible to accommodate both basic and specialized equipment.
If you are interested, please contact Andrew Vinard at firstname.lastname@example.org.
Our Current Collaborators
Genoverde Biosciences, Inc.